Integra LifeSciences Receives FDA Clearances for ALIF Device

Integra LifeSciences received 510(k) clearance from the FDA for the Vu aPOD prime anterior lumbar interbody fusion device, according to a company news release.

Advertisement

The Vu aPOD allows physicians to utilize two fixation options: securing it with two self-tapping bone screws (which does not require additional supplemental fixation) or securing it with the SpinPlate internal buttress plate technology (which requires supplemental fixation). The device’s anatomic design and large graft window help to facilitate fusion.

Read the Integra LifeSciences release on the Vu aPOD.

Read other coverage on Integra LifeSciences:

Integra LifeSciences Launches New Surgical Spine Instruments

– Integra LifeSciences Opens Spine Research, Education and Training Center in Irvine, California

– Integra LifeSciences Reports 8% Increase in Total Revenue

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.